CI vs ELV: stock comparison and AI forecast
Cigna Group (CI) and Elevance Health, Inc. (ELV) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
CI Cigna Group
- Price
- $298.23 +2.6% · 6M
- Market Cap
- $78.80B
- P/E Ratio
- 12.3x
- Size
- large-cap
- AI Forecast
- NO CURRENT FORECAST
ELV Elevance Health, Inc.
- Price
- $413.75 +12.1% · 6M
- Market Cap
- $93.81B
- P/E Ratio
- 18.4x
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- ELV is 1.2 times larger than CI by market capitalization ($93.81B against $78.80B).
- CI trades at 12.3 times trailing earnings, ELV at 18.4 times.
- Over the last six months ELV returned +12.1% and CI +2.6%.
- ELV turns 2.5% of its revenue into net income, against 2.3% for CI.
- CI carries 2.68 times debt per unit of equity, against 1.86 times for ELV.
- CI yields 2.06% in dividends and ELV 1.60%.
- Both companies share the SEC industry classification Hospital & Medical Service Plans.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | CI | ELV |
|---|---|---|
| Market Cap | $78.80B | $93.81B |
| P/E Ratio | 12.34x | 18.43x |
| P/B Ratio | 1.85x | 2.10x |
| Dividend Yield | 2.06% | 1.60% |
| EPS | $24.17 | $23.56 |
| Book Value/Share | $161.29 | $206.80 |
| Revenue/Share | $1068.66 | $934.16 |
| FCF/Share | – | $30.15 |
Profitability & Margins
| Metric | CI | ELV |
|---|---|---|
| ROE | 15.1% | 11.5% |
| ROA | 4.1% | 4.0% |
| ROIC | 9.8% | 6.7% |
| Gross Margin | 20.6% | 89.0% |
| Operating Margin | 3.5% | 2.7% |
| Net Margin | 2.3% | 2.5% |
| EBT Margin | 3.1% | 3.1% |
| Tax Rate | 19.2% | 18.4% |
Financial Health
| Metric | CI | ELV |
|---|---|---|
| Current Ratio | 0.85x | 1.47x |
| Quick Ratio | 0.74x | – |
| D/E Ratio | 2.68x | 1.86x |
| Financial Leverage | 3.69x | 2.86x |
| Interest Coverage | 7.5x | 4.7x |
| Working Capital | -$8.57B | $21.86B |
Cash Flow
| Metric | CI | ELV |
|---|---|---|
| Operating Cash Flow | $10.28B | $7.60B |
| Free Cash Flow | – | $6.51B |
| Capital Spending | – | -$1.08B |
| OCF Growth YoY | 94.2% | 54.6% |
| FCF Growth YoY | – | 72.9% |
| FCF/Sales | – | 3.2% |
| CapEx/Sales | – | 0.5% |
Operational Efficiency
| Metric | CI | ELV |
|---|---|---|
| Asset Turnover | 1.80x | 1.58x |
| Receivables Turnover | 9.2x | – |
| Inventory Turnover | 38.3x | – |
| Fixed Assets Turnover | 75.6x | 43.8x |
| Days Sales Outstanding | 40 days | – |
| Days Inventory | 10 days | – |
| Payables Period | 17 days | – |
| Cash Conversion Cycle | 32 days | – |
Income Statement
| Metric | CI | ELV |
|---|---|---|
| Total Revenue | $282.38B | $201.83B |
| Operating Income | $9.96B | $5.43B |
| Net Income | $6.42B | $5.14B |
| SG&A Expense | $14.16B | $23.04B |
| Cost of Goods Sold | $224.13B | $22.12B |
Dividend & Shareholder Information
| Metric | CI | ELV |
|---|---|---|
| Dividends Per Share | $6.15 | $6.94 |
| Payout Ratio | 25.4% | 29.5% |
| Shares Outstanding | 264M | 216M |
| Net Income Growth | 27.9% | -7.1% |
| EPS Growth | 32.8% | -4.0% |
CI vs ELV: stock comparison and AI forecast
Which is bigger, CI or ELV?
ELV is 1.2 times larger than CI by market capitalization ($93.81B against $78.80B).
Which is cheaper on earnings, CI or ELV?
CI trades at 12.3 times trailing earnings, ELV at 18.4 times.
Which stock performed better over the last six months, CI or ELV?
Over the last six months ELV returned +12.1% and CI +2.6%.
Which one does Intratio's AI model rank higher, CI or ELV?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.